David Degen

Affiliations: 
2013 Rutgers University, New Brunswick, New Brunswick, NJ, United States 
Google:
"David Degen"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Anwar AF, Elbatrawi YM, Degen D, et al. (2024) Total Synthesis of Marformycins A and D. Organic Letters. 26: 10056-10060
Anwar AF, Cain CF, Garza MJ, et al. (2023) Stabilizing pseudouridimycin: Synthesis, RNA-polymerase inhibitory activity, and antibacterial activity of dipeptide-modified analogues. Chemmedchem. e202300474
Elbatrawi YM, Gerrein T, Anwar A, et al. (2022) Total Synthesis of Pargamicin A. Organic Letters
Hassan HM, Degen D, Jang KH, et al. (2022) Correction to: Salinamide F, new depsipeptide antibiotic and inhibitor of bacterial RNA polymerase from a marine-derived Streptomyces sp. The Journal of Antibiotics
Lin W, Mandal S, Degen D, et al. (2019) Structural basis of ECF-σ-factor-dependent transcription initiation. Nature Communications. 10: 710
Lin W, Mandal S, Degen D, et al. (2019) Structural basis of ECF-sigma-factor-dependent transcription initiation. Nature Communications. 10: 710-710
Lin W, Das K, Degen D, et al. (2018) Structural Basis of Transcription Inhibition by Fidaxomicin (Lipiarmycin A3). Molecular Cell
Maffioli SI, Zhang Y, Degen D, et al. (2017) Antibacterial Nucleoside-Analog Inhibitor of Bacterial RNA Polymerase. Cell. 169: 1240-1248.e23
Lin W, Mandal S, Degen D, et al. (2017) Structural Basis of Mycobacterium tuberculosis Transcription and Transcription Inhibition. Molecular Cell
Walker SS, Degen D, Nickbarg E, et al. (2017) Affinity Selection-Mass Spectrometry Identifies a Novel Antibacterial RNA Polymerase Inhibitor. Acs Chemical Biology
See more...